Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients Trial met the primary efficacy ...

5-year Agreement Strengthens Cerus’ Leadership Position in the U.S. Market and Will Expand Patient Access to INTERCEPT Platelets Supplying about 40 percent of the nation’s blood supply, the Red Cross ...

Cerus (NASDAQ:CERS) executives used a presentation and fireside chat at the TD Cowen Healthcare Conference to reiterate the company’s focus on making its INTERCEPT Blood System a global standard of ...

Presentations and abstracts showcase the broad applicability and expected benefits of the INTERCEPT Blood System for platelets, plasma, IFC, and red blood cells CONCORD, Calif.--(BUSINESS WIRE)-- ...

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) announced today two in-country regulatory approvals for INT200, one by the French National Agency for Medicines and Health Product Safety ...

DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical ...

Cerus' Phase 3 trial for INTERCEPT RBCs enrolling a broader patient population requiring RBC transfusion for acute and chronic anemia. Cerus anticipates initiating a modular PMA application to the FDA ...

(Reuters) - U.S. health regulators on Tuesday approved a device developed by Cerus Corp to reduce the risk of infections in blood plasma transmitted during transfusions, such as HIV, hepatitis and ...

Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member ...

To acquire marketing rights from Asian partner BioOne BioOne to get about 1.2 mln Cerus shares at $3.08/shr Cerus to relinquish equity interest in BioOne Aug 24 (Reuters) - Cerus Corp said it will ...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2024. In 2005, the World Health Assembly designated June 14 as World ...

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) today announced the start of the INITIATE study by the German Red Cross Blood Donation Service Baden-Württemberg – Hessen and its subsidiary ...